These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16879212)

  • 41. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
    Lattuada A; Rossi E; Calzarossa C; Candolfi R; Mannucci PM
    Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ADAMTS-13 may not predict disease or outcome in patients with Thrombotic Thrombocytopenic Purpura.
    Rock G; Clark WF; Anderson D; Benny B; Sutton D; Leblond P; Sternbach M; Sontrop J;
    Thromb Res; 2013 Apr; 131(4):308-12. PubMed ID: 23411128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent idiopathic thrombotic thrombocytopenic purpura: a role for vaccination in disease relapse?
    Brodin-Sartorius A; Guebre-Egziabher F; Fouque D; Cozon G; Villar E; Laville M; Juillard L
    Am J Kidney Dis; 2006 Sep; 48(3):e31-4. PubMed ID: 16931205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura.
    Roose E; Schelpe AS; Joly BS; Peetermans M; Verhamme P; Voorberg J; Greinacher A; Deckmyn H; De Meyer SF; Coppo P; Veyradier A; Vanhoorelbeke K
    J Thromb Haemost; 2018 Feb; 16(2):378-388. PubMed ID: 29222940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy?
    Zhou W; Dong L; Ginsburg D; Bouhassira EE; Tsai HM
    J Biol Chem; 2005 Dec; 280(48):39934-41. PubMed ID: 16203734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
    Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I
    Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura.
    Halkidis K; Siegel DL; Zheng XL
    J Thromb Haemost; 2021 Aug; 19(8):1888-1895. PubMed ID: 33834592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura].
    Matsumoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):95-103. PubMed ID: 23629429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.
    Tsai HM
    Kidney Int Suppl; 2009 Feb; (112):S11-4. PubMed ID: 19180123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies.
    Plaimauer B; Kremer Hovinga JA; Juno C; Wolfsegger MJ; Skalicky S; Schmidt M; Grillberger L; Hasslacher M; Knöbl P; Ehrlich H; Scheiflinger F
    J Thromb Haemost; 2011 May; 9(5):936-44. PubMed ID: 21294825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Kremer Hovinga JA; Studt JD; Lämmle B
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
    Scully M; Cohen H; Cavenagh J; Benjamin S; Starke R; Killick S; Mackie I; Machin SJ
    Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory anti-ADAMTS 13 antibodies: measurement and clinical application.
    Scully M
    Blood Rev; 2010 Jan; 24(1):11-6. PubMed ID: 19963308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
    Saha M; McDaniel JK; Zheng XL
    J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome.
    Casina VC; Hu W; Mao JH; Lu RN; Hanby HA; Pickens B; Kan ZY; Lim WK; Mayne L; Ostertag EM; Kacir S; Siegel DL; Englander SW; Zheng XL
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9620-5. PubMed ID: 26203127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.
    Taylor A; Vendramin C; Oosterholt S; Della Pasqua O; Scully M
    J Thromb Haemost; 2019 Jan; 17(1):88-98. PubMed ID: 30475428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.
    Rieger M; Mannucci PM; Kremer Hovinga JA; Herzog A; Gerstenbauer G; Konetschny C; Zimmermann K; Scharrer I; Peyvandi F; Galbusera M; Remuzzi G; Böhm M; Plaimauer B; Lämmle B; Scheiflinger F
    Blood; 2005 Aug; 106(4):1262-7. PubMed ID: 15890682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The value of von Willebrand factor pro-peptide and ADAMTS13 in diagnosis of thrombotic thrombocytopenic purpura].
    Ji J; Liu T; Meng WT; Lu ZP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):807-10. PubMed ID: 22332547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
    Kremer Hovinga JA; Lämmle B
    Hematology Am Soc Hematol Educ Program; 2012; 2012():610-6. PubMed ID: 23233642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.